CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-07 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Option exercise | +15,400 | $7.71 | $119K | 2,038,361 |
| 2024-02-07 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −15,400 | 0 | ||
| 2024-02-07 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Option exercise | +7,400 | $7.71 | $57K | 541,569 |
| 2024-02-07 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −7,400 | 0 | ||
| 2024-01-26 | Graves Adrienne L Director | Grant or award · RSU | +3,119 | 3,119 | ||
| 2024-01-26 | SILVERNAIL LAUREN P Director | Grant or award · RSU | +3,119 | 3,119 | ||
| 2023-11-16 | BAUM MARK L Chief Executive Officer | Purchase | +7,500 | $8.11 | $61K | 2,022,961 |
| 2023-11-15 | Opaleye Management Inc. 10% owner | Purchase | +25,000 | $8.03 | $201K | 3,645,000 |
| 2023-11-10 | SAHAREK JOHN P. Chief Commercial Officer | Option exercise | +20,000 | 242,197 | ||
| 2023-11-10 | SAHAREK JOHN P. Chief Commercial Officer | Shares withheld for taxes | −9,778 | $12.83 | $125K | 232,419 |
| 2023-11-10 | SAHAREK JOHN P. Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2023-09-20 | Opaleye Management Inc. 10% owner | Purchase | +5,983 | $14.49 | $87K | 3,620,000 |
| 2023-09-19 | Opaleye Management Inc. 10% owner | Purchase | +14,017 | $14.65 | $205K | 3,614,017 |
| 2023-08-14 | BAUM MARK L Chief Executive Officer | Purchase | +5,800 | $17.05 | $99K | 2,015,461 |
| 2023-08-14 | Makary Martin A. Director | Purchase | +20,000 | $16.92 | $338K | 45,000 |
| 2023-07-18 | BAUM MARK L Chief Executive Officer | Option exercise | +762,300 | 2,309,629 | ||
| 2023-07-18 | BAUM MARK L Chief Executive Officer | Shares withheld for taxes | −299,968 | $18.23 | $5.5M | 2,009,661 |
| 2023-07-18 | BAUM MARK L Chief Executive Officer | Option exercise · Performance Stock Unit | −762,300 | 0 | ||
| 2023-07-18 | SAHAREK JOHN P. Chief Commercial Officer | Option exercise | +277,200 | 331,277 | ||
| 2023-07-18 | SAHAREK JOHN P. Chief Commercial Officer | Shares withheld for taxes | −109,080 | $18.23 | $2.0M | 222,197 |
Page 5 of 17 · 336 trades